Jan 19,2016 03:56 PM
Nutraplus India Ltd has commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||459.25||34.60||108,102.04||1,155.85||0.89||2,750.41||98.33|
|Dr Reddys Laboratories Ltd||3,876.25||21.97||64,529.60||502.80||0.64||2,837.90||914.23|
|Divis Laboratories Ltd||2,290.75||47.90||60,849.38||360.73||0.70||1,390.49||266.77|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.90. It was subsequently converted into a public limited company with effect from 13 Jun.92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro i... More
Reports by nutraplus-india-ltd
05 Mar 2020
02 Mar 2020
14 Feb 2020
03 Feb 2020
06 Jan 2020
28 Dec 2019